Phosphoinositides and PIPs
IP3/DAG Signaling Pathway
Glial Cells
Nervous Tissue: Glial Cells
Peripheral Nervous System: Ganglia and Nerves
Membrane Lipids
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 1, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Roland Martin1, Mireia Sospedra
1Neuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich, University Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland, Roland.Martin@usz.ch.
Fingolimod, an oral therapy for multiple sclerosis (MS), targets sphingosine 1 phosphate (S1P) and its receptors (S1PRs). Research now explores S1P/S1PR roles within the central nervous system (CNS) in health and disease.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: